FDA Approves Atezolizumab With Chemo Combo for Colon Cancer Katie Lennon

https://www.medscape.com/viewarticle/fda-approves-atezolizumab-chemo-combo-colon-cancer-2026a10011ya?src= The FDA has approved atezolizumab (Tecentriq, Genentech) with a combination of chemotherapies as adjuvant treatment for adult patients and pediatric patients aged 2 years or older with stage III mismatch repair deficient (dMMR) colon cancer.